Adeshwar Meditex Ltd
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of sterile surgical wound dressings and medical disposables[1]
- Market Cap ₹ 26.6 Cr.
- Current Price ₹ 18.4
- High / Low ₹ 21.8 / 13.3
- Stock P/E 21.1
- Book Value ₹ 26.5
- Dividend Yield 0.00 %
- ROCE 5.21 %
- ROE 3.35 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.69 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -3.19% over past five years.
- Company has a low return on equity of 4.89% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 58.60 | 52.92 | 56.12 | 65.97 | 64.76 | 82.36 | 79.85 | 83.71 | 56.10 | |
| 52.96 | 47.44 | 50.64 | 61.22 | 61.39 | 77.14 | 74.66 | 79.29 | 53.33 | |
| Operating Profit | 5.64 | 5.48 | 5.48 | 4.75 | 3.37 | 5.22 | 5.19 | 4.42 | 2.77 |
| OPM % | 9.62% | 10.36% | 9.76% | 7.20% | 5.20% | 6.34% | 6.50% | 5.28% | 4.94% |
| 0.10 | 0.25 | 0.28 | 0.13 | 0.23 | 0.31 | 0.13 | 0.26 | 0.10 | |
| Interest | 1.78 | 2.23 | 2.52 | 2.19 | 2.03 | 2.09 | 1.93 | 1.39 | 0.61 |
| Depreciation | 0.36 | 0.35 | 0.34 | 0.35 | 0.38 | 0.53 | 0.60 | 0.50 | 0.43 |
| Profit before tax | 3.60 | 3.15 | 2.90 | 2.34 | 1.19 | 2.91 | 2.79 | 2.79 | 1.83 |
| Tax % | 29.72% | 28.25% | 27.24% | 28.63% | 33.61% | 28.52% | 27.96% | 26.16% | 31.15% |
| 2.54 | 2.26 | 2.12 | 1.68 | 0.79 | 2.07 | 2.01 | 2.07 | 1.26 | |
| EPS in Rs | 5.10 | 4.54 | 4.03 | 1.60 | 0.55 | 1.43 | 1.39 | 1.43 | 0.87 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | -12% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -7% |
| 3 Years: | -15% |
| TTM: | -36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -9% |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.98 | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | 14.43 | 14.43 | 14.43 |
| Reserves | 8.55 | 10.81 | 13.64 | 10.05 | 16.52 | 18.48 | 20.48 | 22.53 | 23.85 |
| 11.58 | 19.92 | 21.32 | 22.45 | 18.99 | 16.43 | 13.89 | 12.45 | 6.00 | |
| 7.33 | 5.79 | 14.57 | 19.27 | 22.63 | 17.67 | 15.23 | 22.79 | 5.94 | |
| Total Liabilities | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 | 50.22 |
| 2.36 | 2.44 | 2.28 | 2.24 | 3.03 | 3.70 | 3.53 | 2.95 | 2.61 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.02 | 0.04 | 0.08 | 0.08 | 0.10 | 0.10 | 0.10 | 0.00 | 0.00 |
| 30.06 | 39.02 | 52.44 | 59.98 | 69.44 | 63.21 | 60.40 | 69.25 | 47.61 | |
| Total Assets | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 64.03 | 72.20 | 50.22 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| -0.99 | 3.15 | -2.44 | 5.77 | 3.84 | 3.80 | 4.97 | |||
| 1.58 | -0.71 | -1.16 | -1.16 | -0.22 | 0.51 | 0.10 | |||
| -0.07 | -3.11 | 4.44 | -4.63 | -4.36 | -2.66 | -7.09 | |||
| Net Cash Flow | 0.53 | -0.66 | 0.85 | -0.02 | -0.75 | 1.65 | -2.02 | ||
| Free Cash Flow | -1.17 | 2.83 | -3.61 | 4.57 | 3.41 | 3.86 | 4.89 | ||
| CFO/OP | -3% | 81% | -56% | 129% | 90% | 105% | 198% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 108.69 | 134.63 | 181.26 | 150.82 | 183.06 | 123.78 | 115.51 | 152.52 | 135.46 |
| Inventory Days | 64.44 | 112.51 | 119.36 | 174.35 | 168.24 | 127.72 | 138.71 | 126.64 | 159.17 |
| Days Payable | 43.11 | 38.76 | 104.70 | 119.86 | 138.51 | 88.18 | 75.97 | 104.03 | 37.50 |
| Cash Conversion Cycle | 130.02 | 208.39 | 195.93 | 205.31 | 212.79 | 163.33 | 178.25 | 175.13 | 257.13 |
| Working Capital Days | 129.43 | 108.29 | 124.03 | 111.49 | 147.05 | 116.60 | 129.04 | 135.78 | 225.25 |
| ROCE % | 17.69% | 14.27% | 11.22% | 6.93% | 10.07% | 9.62% | 8.27% | 5.21% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Median Remuneration of Employees INR |
|
|||||
| Number of Permanent Employees Number |
||||||
| Debtors Turnover Ratio Ratio |
||||||
| Number of Manufacturing Facilities Number |
||||||
Extracted by Screener AI
Documents
Announcements
-
Clarification Letter On Outcome Of Board Meeting Submitted On May 21, 2026
22 May - Adeshwar Meditex corrected board outcome typos in related party transaction amounts on May 22, 2026.
-
Board Meeting Outcome for Oucome Of Board Meeting For FY 2026-27 Held Today I.E May 21, 2026 Through Video Conferencing
21 May - Board approved FY26 audited results, director resignation/appointment, and discussed up to Rs 40 crore equity raise.
-
Board Meeting Intimation for Board Meeting T Be Held On Thrusday, May 21, 2026 At 12.00 Noon Through Video Conferencing For Approval Of Audited Financial Results Along With Audit Report For Half Year And Financial Year Ended March 31, 2026
14 May - Board meets May 21, 2026 to approve audited FY26 results and note independent director resignation.
-
Board Meeting Outcome for Outcome Of 01St Board Meeting For FY 2026-27 Held Today At Registered Office Of The Company
14 May - Board approved M/s. Basude Makote & Saini as internal auditors for FY 2025-26 to 2027-28.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
28 Apr - Mr. Arun Shankar Koli resigned as Independent Director on 28 April 2026, citing personal and professional commitments.
Business Overview:[1]
AML is engaged in end‑to‑end manufacturing, trading, and distribution of surgical, pharmaceutical, hygiene, protective, and laboratory products, with capabilities
extending to turnkey projects and allied services